Source
From SEC EDGAR
132 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
Excelerate Energy, Inc.
Excelerate Energy Reports Strong Third Quarter 2026 Results
TriplePoint Venture Growth BDC Corp. Announces
Third Quarter 2026 Financial Results
Motorola Solutions Reports Third-Quarter 2026 Financial Results
Company raises full-year revenue and earnings outlook again and increases full-year cash flow expectations
Snap Inc. Announces Third Quarter 2026 Financial Results
Third quarter revenue increased 14% year-over-year to $1,722 million
Warrior Reports Third Quarter 2026 Results
Generates $166.0 million of operating cash flows leading to recently announced $2.00 per-share special dividend
Figma Announces Third Quarter 2026 Financial Results
Q3 revenue grew 43% year-over-year to $391.4 million, $16.4 million above the high-end of prior guidance.
Amplitude Announces Third Quarter 2026 Financial Results
Annual Recurring Revenue of $431 million, up 24% year-over-year
Myriad Genetics Reports Third Quarter 2026 Financial Results;
Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution
CrossAmerica Partners LP Reports Third Quarter 2026 Results
Reported Third Quarter of 2026 Net Income of $8.8 million, Adjusted EBITDA of $38.7 million and Distributable Cash Flow of $21.8 million compared to…
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
HOST HOTELS & RESORTS, INC.
Host Hotels & Resorts, Inc. Reports Results for the Third Quarter of 2026